Aller au contenu principal
Traduction en cours — ce contenu s’affiche en anglais pendant que votre version dans votre langue est en préparation.
Retour aux discussions

AI models need more data about biology, and OpenAI is paying to create it

Healthcare
United States
Commencé September 16, 2026

Last year Ruxandra Teslo, a policy analyst who focuses on clinical trials, posted an idea for supercharging medical AI systems: Use data from failed biotech companies. By bidding at their bankruptcy proceedings, she proposed, it might be possible to obtain detailed regulatory filings, manufacturing strategies, and safety data—types of information usually considered trade secrets. She…

Articles sources

Ajouter une affirmation Analyse 0/5
Need to find a specific claim? Search all statements.
🗳️ Join the conversation
10 affirmations à voter • Your perspective shapes the analysis
📊 Progress to Consensus Analysis Need: 7+ participants, 20+ votes, 3+ votes per statement
Participants 0/7
Statements (10+ recommended) 10/10
Total Votes 0/20
💡 Progress updates live here. Final readiness is confirmed when all three requirements are met.

Your votes count

No account needed — your votes are saved and included in the consensus analysis. Create an account to track your voting history and add statements.

CLAIM Publié par admin • Sep 16, 2026
Using data from failed biotech companies can provide insights that improve future medical innovations.

Traduction en attente

Vote options for this statement: agree, disagree, or unsure
💬 Voir la discussion
Be first to respond
Vote to see results
CLAIM Publié par admin • Sep 16, 2026
Collaboration between AI developers and biotech firms could lead to more responsible data usage and innovation.

Traduction en attente

Vote options for this statement: agree, disagree, or unsure
💬 Voir la discussion
Be first to respond
Vote to see results
CLAIM Publié par admin • Sep 16, 2026
OpenAI's investment in acquiring data from failed biotech companies will significantly enhance medical AI capabilities.

Traduction en attente

Vote options for this statement: agree, disagree, or unsure
💬 Voir la discussion
Be first to respond
Vote to see results
CLAIM Publié par admin • Sep 16, 2026
The reliance on data from failed biotech companies may create biases that hinder the effectiveness of AI models.

Traduction en attente

Vote options for this statement: agree, disagree, or unsure
💬 Voir la discussion
Be first to respond
Vote to see results
CLAIM Publié par admin • Sep 16, 2026
OpenAI's approach to data acquisition should prioritize transparency to maintain public trust.

Traduction en attente

Vote options for this statement: agree, disagree, or unsure
💬 Voir la discussion
Be first to respond
Vote to see results
CLAIM Publié par admin • Sep 16, 2026
OpenAI should focus on ethical guidelines when acquiring data from bankruptcy proceedings of biotech companies.

Traduction en attente

Vote options for this statement: agree, disagree, or unsure
💬 Voir la discussion
Be first to respond
Vote to see results
CLAIM Publié par admin • Sep 16, 2026
Investing in data from failed biotech companies is a crucial step toward understanding complex biological systems.

Traduction en attente

Vote options for this statement: agree, disagree, or unsure
💬 Voir la discussion
Be first to respond
Vote to see results
CLAIM Publié par admin • Sep 16, 2026
Acquiring data from failed biotech companies raises ethical concerns about the exploitation of sensitive information.

Traduction en attente

Vote options for this statement: agree, disagree, or unsure
💬 Voir la discussion
Be first to respond
Vote to see results
CLAIM Publié par admin • Sep 16, 2026
The practice of bidding for data from bankrupt biotech companies undermines the integrity of medical research.

Traduction en attente

Vote options for this statement: agree, disagree, or unsure
💬 Voir la discussion
Be first to respond
Vote to see results
CLAIM Publié par admin • Sep 16, 2026
Using proprietary data from failed biotech companies can provide a competitive edge in AI research and development.

Traduction en attente

Vote options for this statement: agree, disagree, or unsure
💬 Voir la discussion
Be first to respond
Vote to see results

💡 How This Works

  • • Add Statements: Post claims or questions (10-500 characters)
  • • Vote: Agree, Disagree, or Unsure on each statement
  • • Respond: Add detailed pro/con responses with evidence
  • • Consensus: After enough participation, analysis reveals opinion groups and areas of agreement

Society Speaks is open and independent. Your support keeps civic discussion free from advertising and commercial influence.

Support us